Not applicableStudy completedNCT00723645What this trial is testingRate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 279
Testing effectiveness (Phase 2)Study completedNCT01188772What this trial is testingSofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected PatientsWho this might be right forHepatitis C Virus Gilead Sciences 147
Large-scale testing (Phase 3)Ended earlyNCT01095445What this trial is testingEXtended Therapy in Hepatitis C Genotype 3 Infected PatientsWho this might be right forChronic Hepatitis C University Health Network, Toronto 2
Not applicableEnded earlyNCT00727077What this trial is testingPost-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)Who this might be right forHepatitis C, ChronicHepatitis C Merck Sharp & Dohme LLC 3
Early research (Phase 1)Study completedNCT01701336What this trial is testingStudy of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected PatientsWho this might be right forHepatitis C ReiThera Srl 9
Post-approval studies (Phase 4)Ended earlyNCT01465919What this trial is testingEfficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis CWho this might be right forDepression Seoul National University Boramae Hospital 5
Testing effectiveness (Phase 2)Study completedNCT00570336What this trial is testingStudy of CTS-1027 in Hepatitis C PatientsWho this might be right forChronic Hepatitis C Virus Infection Conatus Pharmaceuticals Inc. 87
Very early researchStudy completedNCT04682509What this trial is testingA Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney TransplantationWho this might be right forESRD NYU Langone Health 20
Large-scale testing (Phase 3)Study completedNCT00708500What this trial is testingBoceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 404
Early research (Phase 1)Study completedNCT02339207What this trial is testingFirst in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis C Alios Biopharma Inc. 112
Large-scale testing (Phase 3)Study completedNCT00211692What this trial is testingHepatitis C Treatment Naive Genotype 1 Consensus Interferon TrialWho this might be right forChronic Hepatitis C Minneapolis Veterans Affairs Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT03487848What this trial is testingEvaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) InfectionWho this might be right forHepatitis CChronic Hepatitis Bristol-Myers Squibb 5
Not applicableEnded earlyNCT00867243What this trial is testingPrediction of Hepatitis C Recurrence in Liver Transplant RecipientsWho this might be right forComplication of Transplanted LiverHepatitis C, Chronic Northwestern University 24
Post-approval studies (Phase 4)Study completedNCT00922779What this trial is testingRibavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 6,661
Large-scale testing (Phase 3)Study completedNCT01962441What this trial is testingSOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 601
Large-scale testing (Phase 3)Study completedNCT02216422What this trial is testingEvaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) InfectionWho this might be right forChronic Hepatitis C Virus (HCV) Infection AbbVie 36
Large-scale testing (Phase 3)Study completedNCT00040027What this trial is testingThymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinWho this might be right forHepatitis CHepatitis C, Chronic SciClone Pharmaceuticals 500
Early research (Phase 1)Study completedNCT01817985What this trial is testingEvaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic ImpairmentWho this might be right forChronic Hepatitis C Gilead Sciences 33
Early research (Phase 1)Study completedNCT00389376What this trial is testingPhase I Trial of Silymarin for Chronic Liver DiseasesWho this might be right forHepatitis CNon-Alcoholic Fatty Liver Disease National Center for Complementary and Integrative Health (NCCIH) 56
Testing effectiveness (Phase 2)Study completedNCT02300103What this trial is testingEfficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment StudyWho this might be right forHepatitis C Virus Infection Gilead Sciences 69